Clinical Trial Update: Pyronaridine Artesunate (3:1) in Children and Adults With Acute Plasmodium Vivax Malaria [Phase 3]

View source ↗

Summary

Phase 3 trial update of Pyronaridine Artesunate (3:1) in children and adults with acute Plasmodium vivax malaria; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Pyronaridine-artesunate (pyronaridine/artesunate)

Snippet

Sponsor: Medicines for Malaria Venture | Conditions: Malaria | Phase 3 | Status: COMPLETED | Results posted: 2021-09-20